Disclaimer: This article was published in 2020 and reflects the information available at that time.
  The PDL Professional Officers often see incident reports or regulatory notifications involving high risk medications such as S8 items and benzodiazepines. These incidents can involve incorrect quantities, strengths or formulations. PDL reminds members that extra care should be taken when performing a final check to ensure the patient is receiving the prescribed medication. Pharmacists can be reprimanded for the supply of scheduled medicines that may be considered a risk to the individual patient or the general public, despite there being a valid pr escription. Regulators expect …

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article

Related Practice Alerts

What pharmacists need to know about the new intranasal flu vaccine (FluMist®)
4 March 2026
NationalProfessional activitiesVaccinationPractice support, tips and tools
Learn more
Cover for partnered charting and prescribing activities
24 November 2025
NationalProfessional activitiesPharmacist prescribing
Learn more
Is this the right jab? A vaccination service reminder
20 November 2025
NationalDispensingProfessional activitiesVaccination
Learn more